Evidence map›Paper›PMID 37275871›Full record

ArticleFrontiers in immunology2023

Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with

Muki Shehu Shey, Avuyonke Balfour, Nomawethu Masina, Abulele Bekiswa, Charlotte Schutz, Rene Goliath, Rachel Dielle, Patrick Dmc Katoto, Katalin Andrea Wilkinson, David Lewinsohn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Household contact antigen-speciResearch square · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Muki Shehu SheyDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Avuyonke BalfourDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Nomawethu MasinaDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Abulele BekiswaDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Charlotte SchutzDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Rene GoliathWellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Rachel DielleWellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Patrick Dmc KatotoCochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Katalin Andrea WilkinsonDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
David LewinsohnDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland, OR, United States.
Deborah Anne LewinsohnDivision of Infectious Diseases, Department of Paediatrics, Oregon Health and Science University, Portland, OR, United States.
Graeme MeintjesDepartment of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Wellcome Centre for Infectious Diseases Research in Africa · ZAUniversity of Cape Town · ZAOregon Health & Science University · US

Funding

HIV-associated Tuberculosis Training Program (HATTP)D43TW010559 · FIC · UNIVERSITY OF CAPE TOWN · PI Graeme Ayton Meintjes · 2017 to 2026
$3.0M
FIC NIH HHS D43 TW010559Wellcome Trust 098316Wellcome Trust 203135/Z/16/ZWellcome Trust 211360/Z/18/ZWellcome Trust 214321/Z/18/Z
6 · The paper itself

Abstract

Background: Currently, diagnosis of latent TB infection (LTBI) is based on the secretion of IFN-γ in response to Methods: We enrolled HIV-uninfected healthcare workers who had worked in high TB-exposure environments for 5 years or longer. We screened them for LTBI using the tuberculin skin test and the QuantiFERON-TB Gold Plus assay. We performed multiplex Luminex to measure concentrations of T cell-associated cytokines and chemokines as well as total antibodies in plasma collected from unstimulated fresh whole blood and supernatants from QuantiFERON-TB Gold Plus tubes following incubation of whole blood for 16-24 hours with ESAT6/CFP10 peptides. Results: Samples from 78 individuals were analyzed: 33 resisters (TST<10mm; IGRA<0.35 IU/mL), 33 with LTBI (TST≥10mm and IGRA≥0.35 IU/mL) and 12 discordant (TST=0mm; IGRA≥1.0 IU/mL). There were no differences in concentrations of cytokines and chemokines in plasma between the different groups. Resisters had significantly lower concentrations of IFN-γ, IL-2, TNF-α, MIP-1α, MIP-1β, ITAC, IL-13 and GM-CSF in supernatants compared with LTBI group. There were no significant differences in the concentrations in supernatants of IL-10, IL-1β, IL-17A, IL-21, IL-23, MIP-3α, IL-4, IL-5, IL-6, IL-7, IL-8, Fractalkine and IL-12p70 between the groups. We observed that resisters had similar concentrations of total antibodies (IgG1, IgG2, IgG3, IgG4, IgA, and IgM) in plasma and supernatants compared to the LTBI and discordant groups. Conclusion: Resistance to Mtb infection despite sustained exposure is associated with lower Mtb-specific secretion of Th1-associated cytokines and chemokines. However, resisters showed secreted concentrations after Mtb stimulation of total antibodies and cytokines/chemokines associated with innate and Th17 immune responses similar to those with Mtb infection. This suggests an ability to mount non-IFN-γ immune responses to Mtb in apparent resisters.

Indexed as

Latent InfectionLatent TuberculosisMycobacterium tuberculosisTuberculosisCytokinesHumansTuberculin TestCytokinesantibodieschemokinescytokineslatent TB infection (LTBI)Mycobacterium tuberculosisresister

Identifiers

PMID37275871
PMCPMC10233115
OpenAlexW4377107823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.